Results 281 to 290 of about 3,183,533 (410)

Adverse reactions of immune checkpoint inhibitors combined with angiogenesis inhibitors: A pharmacovigilance analysis of drug-drug interactions. [PDF]

Int J Immunopathol Pharmacol
Ren X, Deng L, Dong X, Bai Y, Li G, Wang Y.   +5 more
europepmc   +1 more source

Angiogenesis inhibitors for advanced hepatocellular carcinoma: in search for the right partner. [PDF]

Ann Transl Med, 2020
Campani C, Rimassa L, Personeni N, Marra F.   +3 more
europepmc   +1 more source

[Research Progress of Angiogenesis Inhibitors Plus EGFR-TKI in EGFR-mutated 
Advanced Non-small Cell Lung Cancer]. [PDF]

Zhongguo Fei Ai Za Zhi, 2022
Li B, Xue J, Wang Y, Huang Z, Liang N, Li S.   +5 more
europepmc   +1 more source

De Novo Design of Integrin α5β1 Modulating Proteins to Enhance Biomaterial Properties

Advanced Materials, EarlyView.
NeoNectins are de novo‐designed miniproteins that selectively bind and stabilize the extended open form of integrin α5β1. When grafted onto biomaterials including hydrogel and titanium, they promote cell attachment and spreading in vitro and promoting tissue integration and bone growth in animal models, demonstrating broad potential for regenerative ...
Xinru Wang, Jordi Guillem‐Marti, Saurav Kumar, David S. Lee, Daniel Cabrerizo‐Aguado, Rachel Werther, Kevin Alexander Estrada Alamo, Yan Ting Zhao, Adam Nguyen, Irina Kopyeva, Buwei Huang, Jing Li, Yuxin Hao, Xinting Li, Aritza Brizuela‐Velasco, Analisa Murray, Stacey Gerben, Anindya Roy, Cole A. DeForest, Timothy Springer, Hannele Ruohola‐Baker, Jonathan A. Cooper, Melody G. Campbell, Jose Maria Manero, Maria‐Pau Ginebra, David Baker   +25 more
wiley   +1 more source

Tissue Inhibitor of Metalloproteinase-1 Alters the Tumorigenicity of Burkitt’s Lymphoma via Divergent Effects on Tumor Growth and Angiogenesis [PDF]

, 2001
Liliana Guédez, Andrew McMarlin, Douglas W. Kingma, Teresa Bennett, Maryalice Stetler‐Stevenson, William G. Stetler‐Stevenson   +5 more
openalex   +1 more source

Risk of HBV reactivation in HCC patients undergoing combination therapy of PD-1 inhibitors and angiogenesis inhibitors in the antiviral era. [PDF]

J Cancer Res Clin Oncol
Wang R, Tan G, Lei D, Li Y, Gong J, Tang Y, Pang H, Luo H, Qin B.   +8 more
europepmc   +1 more source

Intravasation‐On‐µDevice (INVADE): Engineering Dynamic Vascular Interfaces to Study Cancer Cell Intravasation

Advanced Materials, EarlyView.
Cancer metastasis begins with intravasation, a complex process involving cancer‐endothelial interactions. INVADE (Intravasation‐on‐µDevice), a biomimetic microfluidic platform enables high‐throughput analysis of intravasation under controlled conditions.
Fengtao Jiang, Yingqi Zhang, Guocheng Fang, Yao Wang, Alexander Dupuy, Jasmine Jin, Yi Shen, Khoon S Lim, Yinyan Wang, Yu Shrike Zhang, Ann‐Na Cho, Hongxu Lu, Lining Arnold Ju   +12 more
wiley   +1 more source

Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways [PDF]

, 2001
Nicholas S. Duesbery, James H. Resau, Craig P. Webb, Shahriar Koochekpour, Han Koo, Stephen H. Leppla, George F. Vande Woude   +6 more
openalex   +1 more source

Mussel‐Inspired Molecular Strategies for Fabricating Functional Materials With Underwater Adhesion and Self‐Healing Properties

Advanced Materials, EarlyView.
This review systematically examines the nanomechanical mechanisms of mussel‐inspired molecular interactions, primarily investigated by direct force measurement techniques such as surface forces apparatus and atomic force microscopy. The macroscopic adhesive and self‐healing performances of mussel‐inspired functional materials, including coacervates ...
Pan Huang, Hongjian Zhang, Hongbo Zeng
wiley   +1 more source

The Angiogenesis Inhibitor Vasostatin does not Impair Wound Healing at Tumor-Inhibiting Doses [PDF]

, 2001
Bernhard Lange‐Asschenfeldt, Paula Velasco, Michael Streit, Thomas Hawighorst, Michael Detmar, Sandra E. Pike, Giovanna Tosato   +6 more
openalex   +1 more source